scholarly article | Q13442814 |
P50 | author | Piotr Ponikowski | Q22114836 |
Ewa A Jankowska | Q40395675 | ||
Marcin Drozd | Q57204002 | ||
Michał Tkaczyszyn | Q59690884 | ||
Kamil Kobak | Q61145518 | ||
Waldemar Banasiak | Q68692977 | ||
Kinga Węgrzynowska-Teodorczyk | Q88550651 | ||
P2093 | author name string | Irena Flinta | |
P2860 | cites work | Standardisation of spirometry | Q29547365 |
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. | Q34041875 | ||
Iron biology in immune function, muscle metabolism and neuronal functioning | Q34131878 | ||
Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction | Q35903497 | ||
Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life | Q36084695 | ||
Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives | Q36682182 | ||
Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches | Q37883005 | ||
Metabolic and structural impairment of skeletal muscle in heart failure | Q38052031 | ||
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015. | Q38670653 | ||
The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications | Q38708011 | ||
Exercise limitation in chronic heart failure: central role of the periphery | Q41187847 | ||
The "muscle hypothesis" of chronic heart failure | Q41236621 | ||
Respiratory muscle strength in congestive heart failure | Q41968582 | ||
Ferric carboxymaltose in patients with heart failure and iron deficiency | Q43240282 | ||
Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance | Q43495134 | ||
Respiratory muscle function and dyspnea in patients with chronic congestive heart failure | Q44281292 | ||
Iron deficiency in chronic heart failure: an international pooled analysis | Q46257022 | ||
Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology | Q46576175 | ||
Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women | Q47411042 | ||
Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. | Q48014906 | ||
Iron deficiency: an ominous sign in patients with systolic chronic heart failure | Q48155909 | ||
Determinants of physical fitness in males with systolic heart failure. | Q48267002 | ||
ATS/ERS Statement on respiratory muscle testing. | Q51706601 | ||
??? | Q28267062 | ||
Iron supplementation maintains ventilatory threshold and improves energetic efficiency in iron-deficient nonanemic athletes. | Q51796104 | ||
Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group. | Q52218437 | ||
Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). | Q52885994 | ||
Iron Status in Chronic Heart Failure: Impact on Symptoms, Functional Class and Submaximal Exercise Capacity. | Q53243954 | ||
Could the two-minute step test be an alternative to the six-minute walk test for patients with systolic heart failure? | Q57911352 | ||
Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure | Q57911477 | ||
Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy | Q67921197 | ||
Perturbation of mitochondrial composition in muscle by iron deficiency. Implications regarding regulation of mitochondrial assembly | Q70148164 | ||
Effect of iron deficiency on succinate- and NADH-ubiquinone oxidoreductases in skeletal muscle mitochondria | Q70494159 | ||
Iron deficiency in the rat: effects on oxidative metabolism in distinct types of skeletal muscle | Q71403990 | ||
Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure | Q71683216 | ||
Benefit of selective respiratory muscle training on exercise capacity in patients with chronic congestive heart failure | Q72369111 | ||
Evidence of reduced respiratory muscle endurance in patients with heart failure | Q72726518 | ||
Iron supplementation improves endurance after training in iron-depleted, nonanemic women | Q73532458 | ||
P433 | issue | 3 | |
P921 | main subject | heart failure | Q181754 |
muscle weakness | Q270421 | ||
systole | Q496359 | ||
chronic heart failure | Q11829287 | ||
P304 | page(s) | 547-556 | |
P577 | publication date | 2018-03-23 | |
P1433 | published in | Journal of Cachexia, Sarcopenia and Muscle | Q6294897 |
P1476 | title | Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure. | |
P478 | volume | 9 |
Q92307249 | Ageing, demographics, and heart failure |
Q64241834 | Association Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity? |
Q92307253 | Drug therapy in elderly heart failure patients |
Q92307259 | Frailty in patients with heart failure |
Q104074195 | Heart failure in the last year: progress and perspective |
Q92307282 | Heart failure management of the elderly patient: focus on frailty, sarcopaenia, cachexia, and dementia: conclusions |
Q101041624 | High Soluble Transferrin Receptor in Patients With Heart Failure: a Measure of Iron Deficiency And a Strong Predictor of Mortality |
Q58764012 | Iron deficiency as energetic insult to skeletal muscle in chronic diseases |
Q92462134 | Monitoring of iron status in patients with heart failure |
Q92293076 | Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failur |
Q92670169 | Recent advances in the treatment of chronic heart failure |
Q92307265 | Sarcopaenia complicating heart failure |
Search more.